BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hong E, Chen XE, Mao J, Zhou JJ, Chen L, Xu JY, Tao W. Sequential occurrence of T790M mutation and small cell lung cancer transformation in EGFR-positive lung adenocarcinoma: A case report. World J Clin Cases 2022; 10(9): 2836-2843 [PMID: 35434119 DOI: 10.12998/wjcc.v10.i9.2836]
URL: https://www.wjgnet.com/2307-8960/full/v10/i9/2836.htm
Number Citing Articles
1
Shuai Wang, Yongsen Wang, Xuan Wu, Li Yang, Xiaoju Zhang. Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapyWorld Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03687-4
2
GefitinibReactions Weekly 2022; 1905(1): 220 doi: 10.1007/s40278-022-14610-1
3
Jie-Mei Jiang, Zi-Wei Cheng, Li Zhang, Ting-Fei Tan, Teng Zhang, Han-Bing Shi, Kai-Feng Hou, Quan Xia. Proteomic insights into the molecular mechanism of anlotinib inhibition in TP53-mutated non-small cell lung cancerJournal of Proteomics 2025; 316: 105433 doi: 10.1016/j.jprot.2025.105433